Table 1.

Correlation between miR-103a-3p or miR-10a-5p expression and Clinical and biochemical characteristics of patient with IVF-ET treatment.

Variables		N	miR-103a-3p	P-value	miR-10a-5p	P-value
		(total = 106)	Median (Q1–Q3)		Median (Q1–Q3)
Maternal age (years)	<37	77	8.00 (5.08-10.84)	0.913	1.89 (0.75-3.04)	0.962
	≥37	29	8.83 (3.65-12.11)		1.62 (0.77-3.08)
BMI (kg/m2)	<18.5	4	8.74 (5.49-10.90)	0.488	2.27 (0.90-3.57)	0.777
	18.5≤BMI<25	70	8.42 (4.96-11.45)		1.80 (0.64-3.00)
	≥25	32	5.73 (3.11-11.98)		1.94 (1.14-3.15)
FSH (IU/l)	<10	89	7.56 (4.21-10.54)	0.079	1.50 (0.75-2.71)	0.003
	≥10	17	11.7 (6.42-14.97)		3.93 (1.97-4.31)
LH (IU/l)	≤4	58	7.55 (3.82-9.39)	0.03	1.08 (0.55-2.18)	<0.001
	<4	48	9.66 (5.56-13.22)		2.93 (1.41-3.75)
E2 (pg/ml)	≤45	52	8.34 (4.15-11.97)	0.48	1.37 (0.57-2.91)	0.118
	<45	54	7.62 (4.47-11.28)		2.12 (1.07-3.16)
T (pg/ml)	≤30	102	7.92 (4.47-11.32)	0.459	1.66 (0.73-2.92)	0.02
	<30	4	8.90 (4.47-40.71)		3.52 (2.77-4.11)
AMH (ng/ml)	<2	31	9.11 (4.54-12.28)	0.256	2.14 (1.09-3.29)	0.196
	≥2	75	7.70 (4.27-11.06)		1.62 (0.57-2.97)
P4 (ng/ml)	≤4	96	7.85 (4.34-11.19)	0.271	1.66 (0.70-2.95)	0.205
	<4	10	9.51 (6.68-13.80)		2.74 (1.09-3.62)
Diagnosis	Primary infertility	66	8.30 (4.79-11.69)	0.772	2.07 (1.08-3.93)	0.128
	Secondary infertility	40	7.62 (3.79-11.28)		1.44 (0.54-2.70)

Median (Q1–Q3), median (25th - 75th percentiles). BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2,17β-estradiol; T, testosterone; AMH, anti-Müllerian hormone; AFC, antral follicle count. Values of miRNAs are calculated by 2 -ΔCt ×1000, ΔCT = Raw Ct (miRNA) -Raw Ct (U6).